未登录

J

Jan Stenvang

University of Copenhagen

H指数:39

被引数:8,782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tracer-Assisted Shotgun Lipidomics (TASL): A Quantitative Workflow Integrating Stable-Isotope Tracing with Global Lipidome Profiling

示踪辅助 shotgun 脂质组学（TASL）：一种整合稳定同位素示踪与全脂质组谱分析技术的定量工作流程

Analytica Chimica Acta

IF6

2026-03-020

PRE

ABCG transporter and SRPK1 kinase inhibition of chemotherapy resistance: A phase Ib clinical trial of safety and maximum tolerated dose for SCO-101 in combination with gemcitabine and nab-paclitaxel in inoperable pancreatic cancer

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells

MOLECULAR ONCOLOGY

IF4.5

2023-04-284

OA

SCO-101 mediates resensitization of irinotecan (SN38) resistant colorectal cancer cells

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-12-010

PRE

A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-1418

OAAI

Targeting anti-cancer drug resistance in gastro-intestinal cancer: Inhibition of the SRPK1 kinase and degradation of the ABCG2 drug efflux pump

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Re-sensitization of irinotecan/SN38 resistant colorectal cancer cells by SCO-101

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2020-05-0111

OAAI

The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP

IF5.2

2020-03-0414

OAAI

Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer

MOLECULAR ONCOLOGY

IF4.5

2019-10-249

OAAI

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene

IF3.4

2019-06-135

OAAI

lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells

SCIENTIFIC REPORTS

IF3.9

2018-12-1949

OAAI

Sensitization of docetaxel-resistant breast cancer cells to docetaxel by the VRAC modulator SCO-101

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-012

PRE

Repurposing disulfiram as a potential novel treatment of drug-resistant metastatic colorectal cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-014

PRE

Comprehensive genomic analysis of Oesophageal Squamous Cell Carcinoma reveals clinical relevance

SCIENTIFIC REPORTS

IF3.9

2017-11-1032

OAAI

BMP-2 induces EMT and breast cancer sternness through Rb and CD44

CELL DEATH DISCOVERY

IF7

2017-07-1771

OAAI

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer

拓扑异构酶I拷贝数改变可作为伊立替康在转移性结直肠癌中疗效的生物标志物

IF3.4

2017-01-1115

OAAI

miRNA profiling of circulating EpCAM+ extracellular vesicles: promising biomarkers of colorectal cancer

JOURNAL OF EXTRACELLULAR VESICLES

IF14.5

2016-08-2999

OAAI

Drug Resistance in Colorectal Cancer Cell Lines is Partially Associated with Aneuploidy Status in Light of Profiling Gene Expression

JOURNAL OF PROTEOME RESEARCH

IF3.6

2016-08-1615

PREAI

Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment

IF10.8

2016-07-01106

OAAI